Roche (OTCMKTS:RHHBY) Reaches New 1-Year High – Still a Buy?

Roche Holding AG (OTCMKTS:RHHBY)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $49.20 and last traded at $48.87, with a volume of 11266353 shares trading hands. The stock had previously closed at $44.58.

Analyst Ratings Changes

A number of analysts have weighed in on RHHBY shares. Jefferies Financial Group cut shares of Roche from a “hold” rating to a “moderate sell” rating in a research note on Monday, October 27th. HSBC upgraded Roche from a “hold” rating to a “buy” rating and set a $50.00 price objective on the stock in a research report on Thursday, October 2nd. Morgan Stanley reiterated an “underweight” rating on shares of Roche in a research report on Wednesday, October 29th. Hsbc Global Res raised Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a research note on Tuesday, November 11th. Three investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $50.00.

Roche Trading Up 9.6%

The company has a fifty day simple moving average of $42.98 and a 200 day simple moving average of $41.15.

Institutional Trading of Roche

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Hancock Whitney Corp raised its holdings in Roche by 4.8% during the 3rd quarter. Hancock Whitney Corp now owns 24,488 shares of the company’s stock worth $1,024,000 after purchasing an additional 1,116 shares during the last quarter. Verity Asset Management Inc. increased its position in shares of Roche by 20.9% during the third quarter. Verity Asset Management Inc. now owns 10,990 shares of the company’s stock worth $459,000 after buying an additional 1,898 shares during the period. Douglass Winthrop Advisors LLC bought a new position in Roche during the third quarter worth $201,000. Curio Wealth LLC acquired a new position in Roche in the third quarter valued at $25,000. Finally, Vestmark Advisory Solutions Inc. bought a new stake in Roche during the third quarter valued at $597,000.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.